2019
DOI: 10.1016/j.gene.2018.10.011
|View full text |Cite
|
Sign up to set email alerts
|

TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…However, there are fewer reports of SCGB1A1, A2M, ACSL5 and MND1 in lung cancer. In vitro overexpression of TCF21 may inhibit tumor growth and chemoresistance possibly through the AKT signaling pathway (73,74). Upregulation of ITGB8 may promote the expression of tumor metastasis genes and enhance the invasive ability of tumor cells in LUSC by regulating the phosphorylation levels of mitogen-activated protein kinase/extracellular signal-regulated kinase and AKT.…”
Section: Discussionmentioning
confidence: 99%
“…However, there are fewer reports of SCGB1A1, A2M, ACSL5 and MND1 in lung cancer. In vitro overexpression of TCF21 may inhibit tumor growth and chemoresistance possibly through the AKT signaling pathway (73,74). Upregulation of ITGB8 may promote the expression of tumor metastasis genes and enhance the invasive ability of tumor cells in LUSC by regulating the phosphorylation levels of mitogen-activated protein kinase/extracellular signal-regulated kinase and AKT.…”
Section: Discussionmentioning
confidence: 99%
“…MEF2C was also explored regulated by miRNAs, including miR-802, miR-194, and miR-190b [39,40]. Transcription factor 21 (TCF21), a member of the basic helix-loop-helix (bHLH) transcription factors, was methylated and downregulated and inhibited gastric cancer growth and chemoresistance possibly through the AKT signaling pathway in and served as an independent prognostic factor [41]. Promoter methylation of TCF21 was frequently observed and might repress autophagy in the early stage of non-small cell lung cancer (NSCLC) [42].…”
Section: Discussionmentioning
confidence: 99%
“…Cell proliferation is a normal physiological process occurring in every tissue of the body (33). Under normal conditions, cell proliferation and programmed cell death exist in a balance (34). However, in gastric cancer cells, this balance is disrupted by uncontrolled cell proliferation (35).…”
Section: Discussionmentioning
confidence: 99%